Advances in Precision Medicine

ISSN: 2424-9106 (Online)

ISSN: 2424-8592 (Print)

Journal Abbreviation: Adv Precis Med

Publication Frequency: bi-annual

Article Processing Charges (APC): Click here for more details

Publishing Model: Open Access

About the Journal

The journal, Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine.

Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.

All stages in Biomarker Discovery (research and development) as well as its utilization, i.e. identification, validation and application will be covered. Apart from biomarkers and according assays, novel technologies, strategic and general aspects are of interest too. This includes approaches for marker/assay/device development strategies, collaborative approaches and regulatory aspects with impact on personalized medicine. Novel therapies, even if not guided by biomarkers, may be considered if they specifically target a particular molecule and/or a special patient subpopulation. Validation studies are highly encouraged. APM will also consider publishing negative data.

The target audiences of APM are the scientific and healthcare communities of basic scientists and clinicians from academiaregulatory institutions, and industry. This includes pharmadiagnostic and device companies.

Articles include original articles, reviews, perspectives, editorials, commentaries, position papers, conference reports and letters to the editor. The journal welcomes unsolicited article proposals in all categories except for “Editorials”. Authors are encouraged to refer to APM’s “Section Policies” for more information.

APM provides a vital forum for the exchange of important information in all areas of personalized medicine and biomarker research, development and application. We are devoted to making APM a high-quality, frequently cited journal that publishes superior scholarly articles and disseminates the latest advances in the field.

Vol 2, Issue 2

Table of Contents

Review Articles

by Bhupinder Bhullar
547 Views, 273 PDF Downloads
On March 9, 2017, the Canadian parliament overwhelmingly passed the Genetic Non-Discrimination Act to prevent the use of genetic data to deny individuals health insurance, employment, housing or influence their child custody or adoption decisions. Supporters of the law noted the reluctance of Canadians to take genetic tests during clinical care for fear of the data being used against them



Call for Papers

Posted: 2019-03-27 More...
More Announcements...